Related Experiment Video
Updated: May 16, 2026

09:29
Generating Retinal Injury Models in Xenopus Tadpoles
Published on: October 13, 2023
Retinal ganglion cell functional plasticity and optic neuropathy: a comprehensive model
Vittorio Porciatti1, Lori M Ventura
1Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL 33136, USA. VPorciatti@med.miami.edu
Summary
Early glaucoma may show reversible electrical activity changes in retinal ganglion cells before nerve tissue loss. Targeting this modifiable stage offers a new treatment approach for optic neuropathies.
Area of Science:
- Ophthalmology
- Neuroscience
- Computational Biology
Background:
- Glaucoma and optic neuropathies traditionally managed after irreversible visual and nerve tissue loss.
- Emerging evidence indicates retinal ganglion cell (RGC) electrical activity changes precede structural damage.
- Pattern electroretinogram (PERG) detects RGC dysfunction potentially before measurable retinal nerve fiber layer thinning.
Purpose of the Study:
- To model the reversible and inducible changes in RGC electrical activity during a critical pre-mortem dysfunction phase.
- To identify and characterize a modifiable stage of RGC function in early glaucoma.
- To establish a rationale and therapeutic target for altering the disease's natural course.
Main Methods:
- Applied the concept of neural plasticity to model RGC electrical activity.
- Utilized PERG to measure RGC electrical activity.
- Investigated the reversibility and inducibility of PERG alterations.
Main Results:
- PERG alterations in early glaucoma are potentially reversible by lowering intraocular pressure.
- PERG alterations can be induced by specific physiological challenges like head-down body posture.
- Demonstrated a critical period of modifiable RGC dysfunction preceding cell death.
Conclusions:
- RGC electrical activity, detectable by PERG, can be altered before structural optic nerve damage in glaucoma.
- This modifiable stage of RGC dysfunction presents a promising therapeutic target.
- Interventions targeting this stage may change the natural history of glaucoma and optic neuropathies.

